Damora Therapeutics, Inc. Common Stock (DMRA)

Typically moves ±31.24% on earnings
EARNINGS ANALYTICS
search

Damora Therapeutics, Inc. Common Stock (DMRA) has only 2 recorded earnings events on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was +53.04% (Jan 06, 2023) and its biggest decline was -9.44% (Mar 10, 2026).

Earnings reactions

How DMRA moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

2

Avg Abs. Movement

±31.24%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Mar 10, 2026 ☀ PRE -9.44% open_in_new
Jan 06, 2023 ☀ PRE +53.04% open_in_new
event

Earnings Count

2

Total earnings in dataset

trending_up

Avg Abs. Movement

±31.24%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 10 →
10
Funds holding
$91785236
Total value held
Buying
10 added · 0 reduced
Janus Henderson Group Plc
$61441909 NEW BUY
Blackstone Inc.
$13041220 NEW BUY
Blackrock, Inc.
$5761119 +2857.94%
State Street Corp
$4763580 NEW BUY
Morgan Stanley
$2506525 +29.18%

Frequently asked about DMRA earnings

How much does DMRA stock move after earnings? expand_more

Over 2 reports, DMRA has moved an average of ±31.24% the session after earnings, closing higher 50.0% of the time.

What was DMRA's biggest post-earnings move? expand_more

DMRA's largest post-earnings gain on record was +53.04% on Jan 06, 2023, and its largest decline was -9.44% on Mar 10, 2026.

Where can I find Damora Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Damora Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.